Funded by the Spanish Association Against Cancer (AECC) and coordinated by IDIBAPS and the Salamanca Cancer Research Centre, ASPIRE-AECC aims to im...
On Monday 24 February, the Spanish Association Against Cancer (AECC) held a ceremony to announce the research grants awarded in Barcelona during 20...
A new study published in the journal Nature, with the participation of Josep M Llovet and four members of his team at Hospital Clínic-IDIBAPS, desc...
The journal The Lancet has published the results of a phase III clinical trial led by Josep Maria Llovet, from IDIBAPS-Hospital Clínic Barcelona. I...
Clarivate Analytics has published its ranking of the most cited researchers in the world, the Highly Cited Researchers, which identifies the most i...
One of the highlights of the Clínic-IDIBAPS participation in the European Society for Medical Oncology (ESMO) 2024 Congress was Dr. Josep M. Llovet...
Dr. Llovet (Clínic-IDIBAPS) and Dr. Bustelo (CSIC-University of Salamanca) coordinate the ASPIRE-AECC project, which includes 15 hospitals to condu...
Researchers from the Hospital Clínic-IDIBAPS have published a review in Nature Reviews Clinical Oncology about the adjuvant and neoadjuvant treatme...
Endowed with €12 million, the project is coordinated by Prof. Josep M. Llovet, the head of the IDIBAPS group Translational Research in Hepatic Onco...
Clarivate Analytics has published its ranking of the most cited researchers in the world, the Highly Cited Researchers, which identifies the most i...
